Innoviva (INVA) Interest Coverage Ratio (2010 - 2026)
Innoviva (INVA) reported Interest Coverage Ratio of 7.02 for Q1 2026, down 20.2% on a YoY basis from 8.79 in Q1 2025, and down 18.52% quarter-over-quarter from 8.61 in Q3 2025.
Innoviva (INVA) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Innoviva has reported Interest Coverage Ratio for 17 years, with the latest figure at 7.02 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 20.2% year-over-year to 7.02; the trailing twelve-month figure through Mar 2026 stood at 7.63 (down 3.36% YoY), and the FY2025 full-year result was 9.81, up 30.52% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 7.02, down from 8.61 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 19.55 in Q3 2023, with the low at 2.92 in Q1 2022.
- Historically, Interest Coverage Ratio has averaged 4.57 across 5 years, with a median of 7.02 in 2026.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio slumped 151.78% — and 2023, when it surged 1992672.48%.
- Innoviva's Interest Coverage Ratio stood at 0.0 in 2022, then surged by 1992672.48% to 19.55 in 2023, then slumped by 61.92% to 7.45 in 2024, then climbed by 15.67% to 8.61 in 2025, then dropped by 18.52% to 7.02 in 2026.
- The last three Interest Coverage Ratio figures came in at 7.02 (Q1 2026), 8.61 (Q3 2025), and 10.45 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Innoviva | 1.65 Bn | 1.05 Bn | 75.83 Mn | 7.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.02 |
| Sep 30, 2025 | 8.61 |
| Jun 30, 2025 | 10.45 |
| Mar 31, 2025 | 8.79 |
| Sep 30, 2024 | 7.45 |
| Jun 30, 2024 | 9.43 |
| Mar 31, 2024 | -1.75 |
| Sep 30, 2023 | 19.55 |
| Jun 30, 2023 | -2.20 |
| Mar 31, 2023 | -2.56 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | -2.52 |
| Mar 31, 2022 | -2.92 |
| Sep 30, 2021 | 19.74 |
| Jun 30, 2021 | 20.35 |
| Mar 31, 2021 | -1.16 |
| Dec 31, 2020 | -1.39 |
| Sep 30, 2020 | 18.34 |
| Jun 30, 2020 | 16.62 |
| Mar 31, 2020 | 16.85 |